BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 26026071)

  • 21. [Fertility preservation strategies in young women in case of breast cancer or hematologic malignancy].
    Decanter C; Robin G
    Gynecol Obstet Fertil; 2013 Oct; 41(10):597-600. PubMed ID: 24094596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Practical clinical aspects of oocyte vitrification for fertility preservation].
    Courbiere B; Decanter C
    Gynecol Obstet Fertil; 2014 Sep; 42(9):653-6. PubMed ID: 25164159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H; Monnier P; Son WY; Tulandi T; Buckett W
    Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue.
    Yin H; Jiang H; Kristensen SG; Andersen CY
    J Assist Reprod Genet; 2016 Jun; 33(6):741-6. PubMed ID: 26984232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oncofertility and breast cancer].
    Sonigo C; Grynberg M; Bringer S; Sermondade N
    Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
    Cho HW; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW; Kim T
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Where are oncofertility and fertility preservation treatments heading in 2016?
    Harada M; Osuga Y
    Future Oncol; 2016 Oct; 12(20):2313-21. PubMed ID: 27328888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fertility preservation in oncology].
    Chaput L; Grémeau AS; Vorilhon S; Pons H; Chabrot C; Grèze V; Pouly JL; Brugnon F
    Bull Cancer; 2018 Jan; 105(1):99-110. PubMed ID: 29221621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
    Martinez F
    Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro maturation of oocytes: uncommon indications.
    Grynberg M; El Hachem H; de Bantel A; Benard J; le Parco S; Fanchin R
    Fertil Steril; 2013 Apr; 99(5):1182-8. PubMed ID: 23380185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autotransplantation of cryopreserved ovarian tissue--effective method of fertility preservation in cancer patients.
    Gamzatova Z; Komlichenko E; Kostareva A; Galagudza M; Ulrikh E; Zubareva T; Sheveleva T; Nezhentseva E; Kalinina E
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():43-7. PubMed ID: 25200829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fertility sparing in cancer patients.
    Bouchlariotou S; Tsikouras P; Benjamin R; Neulen J
    Minim Invasive Ther Allied Technol; 2012 Jul; 21(4):282-92. PubMed ID: 21919808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mature Oocyte Cryopreservation for Fertility Preservation.
    Liang T; Motan T
    Adv Exp Med Biol; 2016; 951():155-161. PubMed ID: 27837562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fertility preservation for cancer patients. Current options.
    Shalom-Paz E; Holzer HE
    Minerva Ginecol; 2011 Dec; 63(6):517-30. PubMed ID: 22036756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fertility preservation in adolescents and young adults with cancer].
    Rousset-Jablonski C; Chevillon F; Dhedin N; Poirot C
    Bull Cancer; 2016 Dec; 103(12):1019-1034. PubMed ID: 27817861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fertility preservation in the age of assisted reproductive technologies.
    Brezina PR; Kutteh WH; Bailey AP; Ding J; Ke RW; Klosky JL
    Obstet Gynecol Clin North Am; 2015 Mar; 42(1):39-54. PubMed ID: 25681839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Options on fertility preservation in female cancer patients.
    Rodriguez-Wallberg KA; Oktay K
    Cancer Treat Rev; 2012 Aug; 38(5):354-61. PubMed ID: 22078869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.
    Bénard J; Duros S; El Hachem H; Sonigo C; Sifer C; Grynberg M
    Future Oncol; 2016 Jul; 12(14):1731-41. PubMed ID: 27184037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.